Herantis Pharma (Finland) Market Value
| HRTIS Stock | EUR 1.28 0.01 0.79% |
| Symbol | Herantis |
Herantis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Herantis Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Herantis Pharma.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Herantis Pharma on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Herantis Pharma Oyj or generate 0.0% return on investment in Herantis Pharma over 30 days. Herantis Pharma is related to or competes with Sampo Oyj, UPM Kymmene, Wartsila Oyj, Elisa Oyj, and Kesko Oyj. Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics More
Herantis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Herantis Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Herantis Pharma Oyj upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 11.57 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 4.0 |
Herantis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Herantis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Herantis Pharma's standard deviation. In reality, there are many statistical measures that can use Herantis Pharma historical prices to predict the future Herantis Pharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.44) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Herantis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Herantis Pharma Oyj Backtested Returns
Herantis Pharma Oyj holds Efficiency (Sharpe) Ratio of -0.0769, which attests that the entity had a -0.0769% return per unit of risk over the last 3 months. Herantis Pharma Oyj exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Herantis Pharma's Risk Adjusted Performance of (0.06), market risk adjusted performance of (0.43), and Standard Deviation of 2.47 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.48, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Herantis Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Herantis Pharma is expected to be smaller as well. At this point, Herantis Pharma Oyj has a negative expected return of -0.19%. Please make sure to check out Herantis Pharma's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Herantis Pharma Oyj performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.64 |
Very good reverse predictability
Herantis Pharma Oyj has very good reverse predictability. Overlapping area represents the amount of predictability between Herantis Pharma time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Herantis Pharma Oyj price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Herantis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Herantis Pharma Oyj lagged returns against current returns
Autocorrelation, which is Herantis Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Herantis Pharma's stock expected returns. We can calculate the autocorrelation of Herantis Pharma returns to help us make a trade decision. For example, suppose you find that Herantis Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Herantis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Herantis Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Herantis Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Herantis Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Herantis Pharma Lagged Returns
When evaluating Herantis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Herantis Pharma stock have on its future price. Herantis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Herantis Pharma autocorrelation shows the relationship between Herantis Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Herantis Pharma Oyj.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.